For comments, suggestions
Created with Raphaël 2.1.0 21.06.2019 Formal examination (assignment of filing date) 15.07.2019 Preliminary examination 08.11.2019 Establishment of the national regular filing 08.11.2019 Substantive examination 31.10.2020 Publication of the decision of grant (B1) 30.04.2021 Completion of the opposition filing period 31.05.2021 Issuance of patent (C1) 21.06.2024 Valid until 03.07.2024 21.06.2025 Payment of maintenance fee 21.06.2039 Patent expiration date

Patent in force


(11)Number of the document4718
(21)Number of the applicationa 2019 0052
(22)Filing date of the application2019.06.21
 Date of filing the request for examination (de fond) 21.06.2019
(71)Name(s) of applicant(s), code of the countryINSTITUTUL DE CHIMIE, MD; KATHOLIEKE UNIVERSITEIT LEUVEN, BE;
(72)Name(s) of inventor(s), code of the countryKULCITKI Veaceslav, MD; GIRBU Vladilena, MD; PRUTEANU Elena, MD; RENAUD Philippe, CH; DAELEMANS Dirk, BE; MOLLO Ernesto, IT; DEFRANOUX Fanny, FR; UNGUR Nicon, MD;
(73)Name(s) of owner(s), code of the countryINSTITUTUL DE CHIMIE, MD; KATHOLIEKE UNIVERSITEIT LEUVEN, BE;
(54)Title of the inventionMethyl ent-17-amino-kauran-19-oate with selective cytotoxic activity
(13)Kind-of-document code
C1, BOPI 05/2021
B1, BOPI 10/2020
(51)International Patent Classification C07C 229/46 (2006.01); C07C 229/50 (2006.01); A61P 35/00 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2020.10.31
(47)Date of issuance of patent2021.05.31
(74)Patent attorneyJOVMIR Tudor, Str. Miorita nr. 5, bl. 2, ap. 19, MD-2028, Chişinău, Republica Moldova
 Substantive examiner(s)LEVIŢCHI Svetlana
 Payment for maintenance up to the date2024.06.21
Up
/inventions/Details.aspx?id=a+2019+0052